As GLP-1 receptor agonists and dual incretin agents become more common in treating obesity and type 2 diabetes, primary care ...

If you miss a dose of GLP-1, you may be able to take it right away or wait until your next scheduled dose. It depends on the medication you take and how many doses you’ve missed. Glucagon-like peptide ...

Oral GLP-1s for obesity can differ from injectables — including in their effectiveness and dosing. Here's why pills aren’t ...

Influencers, content creators and celebrities across social media platforms are touting the benefits of GLP-1 drugs, but many of them aren’t taking them in the same dosages as most weight loss ...

Before you switch from Wegovy to Zepbound or Ozempic, learn why weight loss plateaus happen and how long you should really ...

Share on Pinterest Could lower-dose and oral GLP-1 drugs help maintain weight loss? Image credit: Design by MNT; Photography by UCG/Getty Images In a clinical trial, adults who switched from high-dose ...

Across health and wellness platforms, GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound are popular topics of discussion. These treatments have fundamentally changed the medical approach ...

NIH opened its research facility construction grants to for-profit companies and local governments. Who can apply, how much is available, and the key rules. Four in 10 Pediatricians Say Children ...

Injectable and oral glucagon-like peptide 1 (GLP-1) medications have changed the way we treat diabetes, obesity, and even certain forms of heart failure. As more forms of these drugs are becoming more ...

Over the past few years, the conversation around GLP-1 receptor agonists has been dominated by extremes: dramatic weight loss in clinical trials, before-and-after transformations on social media, and ...

“As a pharmacist, I've seen social media become a major source of health information for many patients,” says Sue Ojageer, a pharmacist and founder of the concierge health practice PharmaSue. “While ...